A Look At Genworth Financial (GNW) Valuation After Flat Q1 2026 Revenue And Lower Net Income

What Genworth’s latest quarter tells you about the stock

Genworth Financial (GNW) put fresh numbers on the table with its first quarter 2026 report, pairing flat revenue and lower net income with stronger operating cash flow and active share repurchases.

See our latest analysis for Genworth Financial.

Genworth’s share price has held close to US$9.14 despite a 5.9% 1 month share price return and a 30.2% 1 year total shareholder return, which suggests that recent earnings softness and active buybacks are keeping momentum contained rather than accelerating.

If you are weighing Genworth’s mix of cash flow, capital returns, and sector exposure, it can help to compare with other insurers offering growth or income potential through a 18 top founder-led companies

With flat revenue, softer earnings, and an active buyback, Genworth’s recent share gains and discount to analyst targets raise a key question for you: is this an undervalued insurer, or is the market already pricing in future growth?

Price-to-Earnings of 16.8x: Is it justified?

Genworth trades on a P/E of 16.8x at a share price of $9.14, which makes the stock look more expensive than many insurance peers despite its recent earnings softness.

The P/E ratio compares the current share price with earnings per share. A higher multiple often reflects the market paying more today for each dollar of current earnings.

For Genworth, this higher P/E comes alongside a 7.9% earnings decline over the past year and a 38.8% annual decline in earnings over the past 5 years, so the market is not pairing this valuation with clear historical profit growth. With a Return on Equity of 3.4% that is described as low and profit margins easing from 3.2% to 2.9%, the current multiple suggests investors are comfortable paying a premium relative to the company’s recent profitability profile.

Compared with the US Insurance industry average P/E of 11.4x, Genworth’s 16.8x multiple stands out as expensive. It also screens as expensive relative to a peer average P/E of 1.9x. That is a wide gap, and it reinforces that you are paying well above sector and peer averages for each dollar of Genworth’s earnings on current numbers.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-Earnings of 16.8x (OVERVALUED)

However, you also need to consider risks such as long term care insurance obligations and any shift in housing or mortgage conditions that could pressure earnings.

Find out about the key risks to this Genworth Financial narrative.

Another view on value: cash flows vs earnings

The P/E of 16.8x makes Genworth look expensive versus insurance peers, but our DCF model goes further by focusing on future cash flows. On that view, the stock price of $9.14 sits above an estimated future cash flow value of $1.05, which points to an overvalued picture rather than a hidden bargain.

If earnings based metrics and cash flow estimates are sending different signals, it is worth asking which set of assumptions you trust more, and what would need to change in the business for those two views to meet in the middle.

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Genworth Financial for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 51 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

The mixed signals in Genworth’s valuation, cash flows, and recent performance leave room for debate. Consider reviewing the details for yourself, then weigh both sides by checking the 1 key reward and 1 important warning sign

Looking for more investment ideas?

Do not stop with a single insurer when there are other potential opportunities that fit different goals, risk levels, and income needs waiting to be reviewed.

• Target resilient compounding by checking companies with strong financial footing through the solid balance sheet and fundamentals stocks screener (44 results).
• Hunt for potential bargains by scanning quality stocks trading below what their fundamentals might support using the 51 high quality undervalued stocks.
• Prioritise stability and income potential by reviewing companies offering higher yields with the 12 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com